Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Thomas R. Collins

Tom Collins is a freelance writer in South Florida who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.

News

Treatment of several nail disorders reviewed

Author:
Thomas R. Collins
Publish date: February 17, 2023

Treatment with topical beta-blockers can be effective for pyogenic granuloma of the nail, and avoids the scarring seen with surgical removal,...

  • Read More

News

After decade of effort, AGA welcomes change to colonoscopy coverage

Author:
Thomas R. Collins
Publish date: February 7, 2023

The AGA worked for 10 years, alongside other GI societies and patient advocacy groups, to close the “colonoscopy loophole” in federal policy.

  • Read More

News

Developments in wound healing include different treatment options

Author:
Thomas R. Collins
Publish date: February 2, 2023

The TNF blocker infliximab is among the options to consider when treating pyoderma gangrenosum, according to Hadar Lev-Tov, MD...

  • Read More

News

Expert gives tips on less-discussed dermatologic diseases

Author:
Thomas R. Collins
Publish date: February 1, 2023

These diseases are important not to miss and can “also be quite challenging when we think about their management.”

  • Read More

News

Expert offers insights on pediatric dermatology emergencies

Author:
Thomas R. Collins
Publish date: February 1, 2023

Antiepileptic medications are the most common cause of DRESS, followed by antibiotics, but sometimes the trigger is not clear.

  • Read More

News

Dermatologists address cultural competence and unconscious biases in the specialty

Author:
Thomas R. Collins
Publish date: January 30, 2023

Experts agreed that dermatology has work to do to become more diverse and culturally competent, but there are steps that make that possible.

  • Read More

News

AGA venture capital fund makes first investment

Author:
Thomas R. Collins
Publish date: January 19, 2023

“Through our venture fund, gastroenterologists can join AGA to invest in fast-growing, early-stage companies that are transforming care for...

  • Read More

News

Studies provide compelling momentum for mucosal origins hypothesis of rheumatoid arthritis

Author:
Thomas R. Collins
Publish date: November 2, 2022

Two studies provide new evidence and new angles for research into determining the origins of rheumatoid arthritis and potential ways to prevent or...

  • Read More

News

Asthma ED visits predict failed housing inspections

Author:
Thomas R. Collins
Publish date: October 20, 2022

Asthma ED visits increased more than 1 year before a failed HUD inspection but were not elevated at housing units that passed inspection.

  • Read More

News

Pulse oximetry unreliable for carbon monoxide diagnoses

Author:
Thomas R. Collins
Publish date: October 19, 2022

“This method is not accurate enough and should not be used in clinical practice.”

  • Read More

News

Long-acting naltrexone effective in alcohol use disorder

Author:
Thomas R. Collins
Publish date: October 5, 2022

“ED patients are at higher risk of complications for AUD simply because they are in the ED in the first place – initiating AUD treatment in this...

  • Read More

News

Possible sex differences found in response to first treatments for early RA

Author:
Thomas R. Collins
Publish date: September 13, 2022

In a relatively rare, but rigorous, look at sex differences in response to RA treatments, researchers found that men had higher rates of remission...

  • Read More

News

ILD on the rise: Doctors offer tips for diagnosing deadly disease

Author:
Thomas R. Collins
Publish date: September 12, 2022

The COVID-19 pandemic has added a new challenge to making the diagnosis of interstitial lung disease, Dr. Kulkarni said. COVID can lead to...

  • Read More

News

Olokizumab proves noninferior to adalimumab for RA in phase 3 trial

Author:
Thomas R. Collins
Publish date: August 24, 2022

The manufacturer of olokizumab is expected to file for approval in the United States early next year, and the drug could add a new option for...

  • Read More

News

Treat-to-target strategy with tapering proves effective in PsA and axSpA

Author:
Thomas R. Collins
Publish date: June 27, 2022

A trial showed for the first time that disease activity–guided treat-to-target tapering strategies in both psoriatic arthritis and axial...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close